Victrex plc (VCT) Insider Timothy (Tim) J. Cooper Purchases 4 Shares
Victrex plc (LON:VCT) insider Timothy (Tim) J. Cooper bought 4 shares of the company’s stock in a transaction on Tuesday, January 16th. The shares were acquired at an average price of GBX 2,672 ($36.24) per share, for a total transaction of £106.88 ($144.94).
Victrex plc (LON VCT) traded down GBX 100 ($1.36) on Wednesday, hitting GBX 2,570 ($34.85). The company had a trading volume of 402,465 shares, compared to its average volume of 229,467. The firm has a market cap of $2,210.00 and a PE ratio of 2,215.52. Victrex plc has a 1-year low of GBX 1,826 ($24.76) and a 1-year high of GBX 2,772 ($37.59).
The company also recently declared a dividend, which will be paid on Friday, February 16th. Investors of record on Thursday, February 1st will be issued a GBX 109.60 ($1.49) dividend. The ex-dividend date of this dividend is Thursday, February 1st. This represents a dividend yield of 4.31%. This is a boost from Victrex’s previous dividend of $12.20.
COPYRIGHT VIOLATION NOTICE: “Victrex plc (VCT) Insider Timothy (Tim) J. Cooper Purchases 4 Shares” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/17/victrex-plc-vct-insider-timothy-tim-j-cooper-purchases-4-shares.html.
Victrex Company Profile
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.